MXPA97002246A - Process for producing aspartase and l-aspartic acid - Google Patents
Process for producing aspartase and l-aspartic acidInfo
- Publication number
- MXPA97002246A MXPA97002246A MXPA/A/1997/002246A MX9702246A MXPA97002246A MX PA97002246 A MXPA97002246 A MX PA97002246A MX 9702246 A MX9702246 A MX 9702246A MX PA97002246 A MXPA97002246 A MX PA97002246A
- Authority
- MX
- Mexico
- Prior art keywords
- aspartase
- aspartic acid
- producing
- culture
- medium
- Prior art date
Links
- 108091022072 Aspartate ammonia-lyases Proteins 0.000 title claims abstract description 61
- 229960005261 Aspartic Acid Drugs 0.000 title claims abstract description 29
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 title claims abstract description 29
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 25
- VZCYOOQTPOCHFL-OWOJBTEDSA-N (E)-but-2-enedioate;hydron Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 24
- 244000005700 microbiome Species 0.000 claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 239000001530 fumaric acid Substances 0.000 claims abstract description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000588722 Escherichia Species 0.000 claims abstract description 8
- 230000012010 growth Effects 0.000 claims abstract description 6
- 230000003698 anagen phase Effects 0.000 claims abstract description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 5
- 239000001301 oxygen Substances 0.000 claims abstract description 5
- 230000000813 microbial Effects 0.000 claims abstract description 4
- 210000004027 cells Anatomy 0.000 description 26
- 239000002609 media Substances 0.000 description 25
- 241000588724 Escherichia coli Species 0.000 description 15
- 238000005273 aeration Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 102100001972 FH Human genes 0.000 description 9
- 108010036781 Fumarate Hydratase Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000002068 genetic Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229960003563 Calcium Carbonate Drugs 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 240000005158 Phaseolus vulgaris Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K Tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000005824 corn Nutrition 0.000 description 2
- 230000003247 decreasing Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229940079866 intestinal antibiotics Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- ZRIUUUJAJJNDSS-UHFFFAOYSA-N Ammonium phosphates Chemical compound [NH4+].[NH4+].[NH4+].[O-]P([O-])([O-])=O ZRIUUUJAJJNDSS-UHFFFAOYSA-N 0.000 description 1
- 239000012619 Butyl Sepharose® Substances 0.000 description 1
- 229940041514 Candida albicans extract Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229960000355 Copper Sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L Iron(II) sulfate Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H Magnesium phosphate tribasic Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M Monopotassium phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229940116542 OTHER NUTRIENTS in ATC Drugs 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L Sodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000024881 catalytic activity Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 210000004748 cultured cells Anatomy 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- -1 diethylaminoethyl Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002209 hydrophobic Effects 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
Disclosed are a process for producing aspartase which comprises culturing a microorganism belonging to the genus Escherichia being capable of producing aspartase in a medium until aspartase is produced and accumulated in the culture, and recovering aspartase therefrom, wherein dissolved oxygen concentration of the medium is in the range of 0 to 1 ppm on the stage that microbial growth is middle and/or late logarithmic growth phase;and a process for producing L-aspartic acid which comprises converting fumaric acid and ammonia into L-aspartic acid in an aqueous medium in the presence of an enzyme source, wherein said enzyme source is a culture produced in accordance with said aspartase-producing process, cells isolated from the culture, or processed cells thereof.
Description
PROCESS FOR PRODUCING ASPARTASE AND PROCESS FOR PRODUCING ACID L-ASPART CO DESCRIPTION OF THE INVENTION The present invention relates to a process for producing aspartase using a microorganism belonging to the genus Escherichia that has the ability to produce and accumulate aspartase and with a process to produce L-aspartic acid using aspartase. Hitherto many reports have been made that relate to processes for producing L-aspartic acid from fumaric acid and ammonia using aspartase as produced by microorganisms (Japanese Patent Application, Examined, Published Nos. 54-12553 and 57). -18867). As such microorganisms, those belonging to the genera Escherichia and Corynebacterium are known and some attempts so far have been made to obtain mutants with high aspartase productivity by means of genetic recombination technology (Japanese Patent Application Unexamined, Published Nos. 60-133883 and 5-30977). In the process to produce aspartase in a large amount using such microorganisms of the genera Escherichia and Corynebacterium, fumaric acid, which is expensive, is used as the nutrient source. In the process to produce aspartase using a transformant with high aspartase productivity as obtained by means of genetic recombination, the antibiotics are added to the seed media to ensure the stability of the transformer's aspartase productivity. It is known that when a microorganism of the type capable of producing and accumulating aspartase together with fumarase is used to produce aspartase and aspartase is used to produce L-aspartic acid, some by-products other than L-aspartic acid are produced because the fumarase decreases the yield of the intended L-aspartic acid.
To avoid the reduction in the yield of L-aspartic acid, the system is treated with heat or treated with acids after the production of aspartase, thereby eliminating the fumarase activity of the system (Kagaku Kogyo, 58., 878 , 1994; Examined Japanese Patent Publication,
Published No. 3-55103). The prior art techniques are problematic in that the processes, using microorganisms that are capable of producing aspartase to produce large amounts of aspartase, require fumaric acid, which is
expensive, as the nutrient source; The processes that use transformants with high aspartase productivity as obtained by means of genetic recombination, require antibiotics to be added to the planting media to ensure the stability of aspartase productivity.
the transformants; and in the processes for producing L-aspartic acid using the microorganisms that can produce and accumulate fumarases in addition to the intended aspartase, the production of by-products other than the intended L-aspartic acid is inevitable. 5 According to the present. invention, a process for producing aspartase is provided, which comprises cultivating a microorganism belonging to the genus Escherichia that is capable of producing aspartase in a medium until the aspartase is produced and accumulated in the culture.
and recover from them the aspartase, in which the dissolved oxygen concentration of the medium is in the range of 0 to 1 ppm in the stage in which the microbial growth is in the middle and / or late logarithmic growth phase; and a process for producing L-aspartic acid, which comprises
Converting fumaric acid and ammonia to L-aspartic acid in an aqueous medium in the presence of an enzyme source, in which the enzyme source is a culture produced according to the process for producing aspartase, the cells isolated from the culture or your processed cells. In the present invention, any microorganism can be used as long as it belongs to the genus Escherichia, preferably Escherichia coli, and is capable of producing aspartase, preferably producing a large amount of aspartase, it can be used.
In general, Escherichia coli may have the ability to produce an accumulated aspartase. As an example, Escherichia coli ATCC-11303 is mentioned. The suitable microorganism used in the present invention can be obtained as a mutant strain that produces a large amount of aspartase by subjecting the microorganisms that produce aspartase belonging to the genus Escherichia to conventional mutagenesis, screening the resulting mutants to select those capable of growing plus
rapidly in minimal media containing L-aspartic acid as the sole nitrogen source (Appl. Env. Microbiol., 48., 1072, 1984). Such mutant strains include Escherichia coli EAPc7, Escherichia coli EAPc244, Escherichia coli EAPc28, Escherichia coli EAPcllO,
'Escherichia coli EAPcl30 (Japanese Application Without Ex: aminar, Published No. 60-133883) and Escherichia coli
# H-9183 Suitable microorganisms used in the present invention can be obtained as a transformant
that produces a large amount of aspartase by the use of genetic recombination technology. Such transformants include Escherichia coli TA5003, Escherichia coli TA5004 and Escherichia coli TA5005 (Japanese Unexamined Patent Application, Published No. 60-133883).
It is possible to produce aspartase by growing a microorganism of the present invention according to the process mentioned in the following. As the medium, any of a natural medium and a synthetic medium can be used as long as it contains carbon source, nitrogen sources, inorganic substances and other nutrients required by the microorganism used, etc., which can be assimilated by the microorganism used. and the microorganism can be
cultivated efficiently in it. As the carbon source, the carbohydrate such as glucose, fructose, sucrose, melases containing these and still starch and starch hydrolysates; organic acid such as acetic acid, fumaric acid, lactic acid and acid
propionic; and alcohol such as ethanol, glycerin and propanol, etc., can be used. As the source of nitrogen, ammonia, various inorganic or organic ammonium salts such as ammonium chloride, ammonium sulfate, ammonium acetate and phosphate
ammonium; amines; other nitrogen-containing compounds; Peptone, meat extract, yeast extract, distilled corn liquor, casein hydrolyzate, bean turtle, hydrolyzed bean turtle, various cultured cells and digested product of cells, etc., can be
used.
As the inorganic substance, the potassium diacid phosphate, dipotassium acid phosphate, magnesium phosphate, magnesium sulfate, sodium chloride, ferrous sulfate, manganese sulfate, copper sulfate and calcium carbonate,
etc., can be used. The conditions of aeration or conditions of agitation during cultivation have great influences on the level of accumulation of aspartase. The microorganism of the present invention is grown under aerobic conditions until the early logarithmic growth phase, then it is grown in a controlled aiation condition in which the concentration of oxygen dissolved in the medium is in the range of 0 to 1 ppm, therefore, the production and accumulation of fumarase is reduced and the production and accumulation of the destined aspartase is increased. The cultivation is carried out at a temperature of 20 to 40 ° C, preferably 25 to 37 ° C. The pH of the medium is in the range of 5 to 9, preferably 6 to 8. The pH is adjusted with calcium carbonate, inorganic or organic acid, alkaline solution, ammonia, a pH buffering agent or the like. Generally, after cultivating for 3 to 24 hours, a large amount of aspartase accumulates in the cells of the microorganism.
After the end of the culture, the aspartase is isolated and purified from the culture by a conventional method. For example, the culture is centrifuged to collect the cells and the cells are washed and disintegrated with an ultrasonic disintegrator, a French press, a Manton-Gaulin homogenizer, a Dyno mill or the like to obtain an extract without cells. The extract without cells is centrifuged and the resulting supernatant is subjected to desalination with ammonium sulfate or the like, for the exchange chromatography
anionic with diethylaminoethyl (DEAE) -Sepharose or the like, to hydrophobic chromatography with butyl-Sepharose, phenyl-Sepharose or the like, to gel permeation with a molecular sieve or the like, or to electrophoresis such as isoelectric electrophoresis, whereby a
pure product of aspartase. The activity of the aspartase enzyme can be determined in the manner mentioned in the following. A sample is incubated in an aqueous solution comprising ammonium fumarate (160 g / liter, pH 8.7) and gCl ^
(0.2 mM) at 37 ° C for 60 minutes. The resulting L-aspartic acid was determined using high pressure liquid chromatography. The activity of the enzyme of aspartase is represented in units, with a unit (U) that is defined as the activity capable of producing 1 / mol of acid
L-aspartic in one minute, is mentioned as a unit (U).
The fumarase activity can be determined in the manner mentioned in the following. A sample is incubated in an aqueous solution comprising sodium fumarate (1 M, pH 8.0) at 37 ° C for 30 minutes. The resulting malic acid is determined using high pressure liquid chromatography. The activity of the sample that produces 1 μmol of malic acid in one minute is mentioned as a unit (U). L-aspartic acid can be produced by using, as an enzyme source, a culture containing aspartase in a large amount obtained in the above process to produce aspartase, the cells isolated from the culture, or their processed cells, by the addition of fumaric acid and ammonia to an aqueous medium suitable for the reaction of the enzyme to produce and accumulate therein L-aspartic acid and by recovering them from the accumulated L-aspartic acid. The processed cells include dry cells, lyophilized cells, surfactant treated cells, enzymatically treated cells, ultrasonically treated cells, mechanically ground cells, solvent treated cells, protein-containing fractions of the cells and immobilized products of the processed cells or cells.
The enzyme which is obtained by extraction of the cells and has aspartase enzyme activity, its purified preparation and its immobilized products are also used as the processed cells. The aqueous medium includes water, buffer such as phosphate buffer, carbonate buffer, acetate buffer, borate buffer, citrate buffer and tris buffer, alcohol such as methanol and ethanol, ester such as ethyl acetate, ketone such as
acetone and amide such as acetamide. The culture obtained in the above process to produce aspartase is also employed as the aqueous medium, either directly or after having been diluted 1 to 10 times, preferably 2 to 6 times. The activity of the enzyme source in the reaction system can be determined, for example, depending on the amount of the substrate used. In general, the activity of the enzyme in the aqueous medium can be in the range of 10 to 1000 U / liter, preferably 50 to 300 U / liter. The amount of fumaric acid in the aqueous medium can usually be in the range of 50 to 200 g / liter. The reaction of fumaric acid with ammonia in an aqueous medium in the presence of an enzyme source is usually carried out at 10 to 50 ° C and at a pH of 7.5 to 9.5 during
0.5 to 20 hours.
# After the end of the reaction, an acid such as sulfuric acid and hydrochloric acid is added to the reaction mixture to adjust the pH to 2.7, so that the L-aspartic acid formed crystallizes and the crystallized 5 L-aspartic acid it is collected from the reaction mixture. The present invention is described in more detail with reference to the following examples, which, however, are not intended to restrict the scope of the invention.
invention. EXAMPLE Example 1: Production of Aspartase Escherichia coli ATCC-11303 (a wild-type strain) that is capable of producing aspartase and Escherichia
coli H-9183 derived from E. coli ATCC-11303 and which is capable of producing a large amount of aspartase were used. Strain H-9183 was derived from strain ATCC-11303 according to the process mentioned in the following. Strain ATCC-11303 was subjected to mutagenesis in a
Aqueous solution containing N-methyl-N1-nitro-N-nitrosoguanidine (0.25 mg / ml) at 30 ° C for 30 minutes. Approximately 80,000 strains were obtained by mutagenesis and were screened based on their growth rates in a minimal medium containing L-aspartic acid as the only
source of nitrogen. Among the strains selected in this way, strain H-9183, which has a high growth rate, is obtained as a strain capable of producing a large amount of aspartase. Each of the strains ATCC-11303 and H-9183 were cultured with agitation aerobically at 30 ° C for 12 hours in a seed medium containing 2% glucose, 2% peptone, 0.3% meat lime and 0.5 % calcium carbonate. The resulting seed culture (10 ml) was inoculated into 1 liter of a medium containing 2% glucose, 0.5%
distilled corn liquor, 0.03% ammonium sulfate and 0.3% potassium dihydrogen phosphate in a 2 1 fermenting vessel and the culture is carried out at 30 ° C with stirring at 800 rpm. During cultivation, the pH of the medium is maintained at approximately 6.5 + 0.2 with aqueous ammonia and the culture is
carried out until the glucose in the medium was completely consumed. The cultivation was carried out in two ways; one that is to grow the microorganism aerobically by aeration of the medium at a rate of aeration of 1 liter / minute during the entire period of cultivation and the other that is to cultivate
the microorganism with conversion of the aerobic condition at a rate of aeration of 1 liter / minute in a condition of controlled aeration during the course of the culture period. The conversion time of the aerobic condition into a controlled aeration condition was at the stage in the
that microbial growth is in the growth phase? logarithmic medium. The amount of aeration in the medium was decreased to make the dissolved oxygen concentration of the medium in the range of 0 to 1 ppm as for the controlled aeration condition. After the end of the culture, the aspartase activity and the fumarase activity of the microorganism cells were determined. The results are shown in Table 1.
Table 1
Both of strain ATCC-11303 and strain H-9183 that have been cultured under controlled aeration conditions have increased aspartase activities and decreased fumarase activities, respectively. Example 2: Production of L-Aspartic Acid 15 The cultures of strain H-9183 as obtained in Example 1 were suitably diluted, for which fumaric acid was added at the concentration of 100 g / liter. Then, the ammonia is added to adjust the pH to 8.7. The reaction is carried out at 30 ° C with gentle agitation. Results are shown in table 2.
Table 2
F
The results show that the L-aspartic acid productivity and the conversion in the product were increased in the crop as obtained in the condition through aeration followed by controlled aeration. Example 3: Production of L-aspartic acid The culture of strain H-9183 is obtained in the controlled aeration condition in Example 1, centrifuged to isolate the cells. The cells are suspended in a phosphate buffer (0.01 M potassium phosphate;
of 7.4) and homogenized together with glass beads to disintegrate them into an extract. The extract is passed through a column filled with a resin, Duolite A-7 so it makes the existing protein in the extract adsorbed by the resin.
Then, an aqueous solution of fumaric acid (150 g / liter, adjusted to pH 8.5 with aqueous ammonia) is passed through the column at 37 ° C whereby a solution of L-aspartic acid (171 g) is obtained / liter). The pH of the solution (1 liter) is adjusted to 2.7 with sulfuric acid and 161 g of crystals of L-aspartic acid are obtained. INDUSTRIAL APPLICABILITY According to the process of the present invention to produce aspartase, it is possible to produce a large
amount of aspartase with decrease of a fumarase / aspartase ratio. Furthermore, by using the aspartase produced in this form according to the invention, it is possible to produce pure L-aspartic acid containing less amount of by-products. fifteen
i
Claims (2)
- # CLAIMS 1. A process to produce aspartase, characterized in that it comprises cultivating a microorganism belonging to the genus Escherichia that is able to produce aepartase in a medium until the aspartase is produced and accumulated in the culture and recover the aspartase therefrom, in that the dissolved oxygen concentration of the medium is in the range of 0 to 1 ppm in the microbial growth stage is in the middle and / or late logarithmic growth phase. * 10
- 2. A process for producing L-aspartic acid, which comprises converting fumaric acid and ammonia to L-aspartic acid in an aqueous medium in the presence of an enzyme source, in which the enzyme source is a culture produced according to the process in accordance with the 15 claim 1, the cells isolated from the culture or their processed cells.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8/75989 | 1996-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA97002246A true MXPA97002246A (en) | 2002-05-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3698758B2 (en) | Method for producing L-leucine by fermentation | |
JP3966583B2 (en) | Method for producing L-amino acid by fermentation | |
JP3301140B2 (en) | Method for producing L-glutamic acid by fermentation method | |
US5916782A (en) | Process for producing aspartase and process for producing L-aspartic acid | |
US5783428A (en) | Method of producing fumaric acid | |
JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
DE69738080T2 (en) | BIO-CATALYSTS WITH AMIN ACYLASE ACTIVITY | |
EP0386476B1 (en) | Process for producing L-alanine | |
US3458400A (en) | Process for producing l-alanine | |
JPH0576391A (en) | Biological engineering method for preparing s-(+)-2,2-dimethylcyclopropanecarboxamide | |
US5869300A (en) | Method for producing L-glutamic acid by continuous fermentation | |
MXPA97002246A (en) | Process for producing aspartase and l-aspartic acid | |
EP0455170B1 (en) | Process for culturing microorganisms of the genus Pseudomonas and process for producing L-alanine using said microorganisms | |
CA1302931C (en) | Preparation of pyruvic acid | |
JPS58201985A (en) | Production of glucose dehydrogenase | |
JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
EP0295622B1 (en) | Process for producing l-tryptophan | |
JP2002281993A (en) | Method for producing shikimic acid | |
EP0215414B1 (en) | Process for producing l-phenylalanine | |
US6238895B1 (en) | Production of aspartic and malic acids with microbacterium | |
JPH09313194A (en) | Production of l-aspartic acid | |
US3696000A (en) | Process for the production of alkaline proteinase | |
JPS6128398A (en) | Preparation of l-valine | |
Turner | Biological catalysis and biotechnology | |
JPH0378999B2 (en) |